Paul Shields serves as Executive at UNIGENE LABORATORIES INC, where they oversee executive responsibilities. Since joining the company, Paul Shields has executed 13 insider transactions totaling $251.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 21, 2011 involved purchasing 2,000 shares valued at $1.1K.
Paul Shields currently holds 13,100 shares of UNIGENE LABORATORIES INC (UGNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Shields has been a net seller of UGNE stock. They have purchased $1.1K and sold $250.4K worth of shares.
Paul Shields's most recent insider trade was on Dec 21, 2011, when they purchased 2,000 shares at $0.53 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 2, 2009 | UGNE | $13.7K | Sale | 14,762 | $0.93 | Discretionary |
| Dec 1, 2009 | UGNE | $25.6K | Sale | 27,488 | $0.93 | Discretionary |
| Nov 30, 2009 | UGNE | $23.7K | Sale | 25,500 | $0.93 | Discretionary |
| Nov 25, 2009 | UGNE | $14.3K | Option Exercise | 14,195 | $1.01 | Discretionary |
| Oct 27, 2009 | UGNE | $7.8K | Option Exercise | 25,000 | $0.31 | Discretionary |
| Oct 27, 2009 | UGNE | $26.9K | Option Exercise | 42,750 | $0.63 | Discretionary |
| Apr 17, 2008 | UGNE | $0 | Award | 14,035 | $N/A | Discretionary |
| Mar 22, 2006 | UGNE | $148.4K | Sale | 40,000 | $3.71 | Discretionary |
| Mar 22, 2006 | UGNE | $12.4K | Option Exercise | 40,000 | $0.31 | Discretionary |
| Mar 21, 2006 | UGNE | $3.1K | Option Exercise | 10,000 | $0.31 | Discretionary |
| Mar 21, 2006 | UGNE | $39.0K | Sale | 10,000 | $3.90 | Discretionary |